Creative Arts Therapy on Body Image, Self-esteem, Anxiety and Depression in Post-Treatment Prostate Cancer Patients

Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Jun 6, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how creative arts therapy, specifically drawing and painting, can help improve the health and well-being of men who have completed treatment for localized prostate cancer. The researchers want to see if this type of therapy can positively impact body image, self-esteem, anxiety, and depression in these patients. Participants will take part in five art therapy sessions, where they’ll engage in activities that encourage self-expression and reflection, all in a supportive environment.

To be eligible for the study, participants must be adult men diagnosed with localized prostate cancer and have completed their treatment more than a year ago. They should not be undergoing any active treatment at the time of the study. Participants will need to be able to read Chinese and communicate in Cantonese, and they must have the physical ability to attend the sessions. By joining this trial, participants can expect to explore their feelings in a creative way, while also contributing to important research that could help other prostate cancer patients in the future.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Adult participants diagnosed with localised prostate cancer, regardless of the stage and age 18 years or older;
• • are not currently receiving active therapy, including chemotherapy, radiotherapy or surgical treatment, by the time of the study or completed treatment more than one year ago and are not on any active treatment;
• • were being followed up by the urology team or Department of Surgery at the Chinese University of Hong Kong;
• • are willing to participate in the study;
• • are able to read Chinese and communicate in Cantonese;
• • are physically able to attend and complete art therapy sessions;
• • do not have significant comorbidities, including cerebrovascular accident, severe depression, or dementia that could affect their ability to participate in the study;
• • signed an informed consent form.
• Exclusion Criteria:
• • Adult participants diagnosed with a mixed type of terminal cancer;
• • are undergoing active therapy;
• • have participated in other art therapy interventions;
• • have physical issues preventing them from holding a pen;
• • have a mental status and/or communication problem that might compromise their capacity to give informed consent;
• • have significant comorbidities such as cerebrovascular accident, severe depression, or dementia, as determined by standardized screening tools a score of 20-27 on the Patient Health Questionnaire and score 25 or less on the Mini-Mental State Examination.